Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Large-scale testing (Phase 3)Study completedNCT00775931
What this trial is testing

Allogeneic Transplantation For Severe Osteopetrosis

Who this might be right for
Severe Osteopetrosis
Masonic Cancer Center, University of Minnesota 7
Not applicableStudy completedNCT01521039
What this trial is testing

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft-versus-Host DiseaseAllogeneic Stem Cell Transplant
Ohio State University Comprehensive Cancer Center 259
Testing effectiveness (Phase 2)WithdrawnNCT00025519
What this trial is testing

Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01168219
What this trial is testing

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic Leukemia+17 more
National Cancer Institute (NCI) 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT01985061
What this trial is testing

Evaluation of 3 Different Doses of IV Busulfan

Who this might be right for
Myelodysplastic SyndromeAcute Myeloid Leukemia
Institut Paoli-Calmettes 177
Early research (Phase 1)Study completedNCT01020539
What this trial is testing

Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeJuvenile Myelomonocytic Leukemia
Columbia University 18
Testing effectiveness (Phase 2)Ended earlyNCT00945126
What this trial is testing

Allogeneic Stem Cell Transplantation in Pediatric Patients With Malignant and Non-malignant High-risk Diseases

Who this might be right for
Malignant and Non-malignant High Risk Diseases
Johann Wolfgang Goethe University Hospital 68
Testing effectiveness (Phase 2)Study completedNCT01310010
What this trial is testing

Study of Dasatinib to Treat Philadelphia Positive Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 30
Testing effectiveness (Phase 2)WithdrawnNCT00396968
What this trial is testing

AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndromes
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Ended earlyNCT01856582
What this trial is testing

CD34+ Stem Cell Infusion to Augment Graft Function

Who this might be right for
Waning Donor ChimerismWaning Immune FunctionPrimary Immunodeficiency Disease(s)+1 more
Children's Hospital Medical Center, Cincinnati 23
Testing effectiveness (Phase 2)Ended earlyNCT01475162
What this trial is testing

Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease

Who this might be right for
Acute Graft Versus Host Disease
Medical College of Wisconsin 14
Not applicableUnknownNCT05590091
What this trial is testing

Study on Intelligent Nutrition Support Therapy for Hematopoietic Stem Cell Transplantation Recipients

Who this might be right for
Nutrition Aspect of CancerStem Cell Transplant Complications
Hebei Yanda Ludaopei Hospital 106
Not applicableStudy completedNCT00128960
What this trial is testing

Quality of Life in Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Long Term Psychological Affects on HSCT
National Institutes of Health Clinical Center (CC) 173
Not applicableStudy completedNCT02270346
What this trial is testing

Inspiratory Muscle Training in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Gazi University 40
Testing effectiveness (Phase 2)Study completedNCT01043640
What this trial is testing

Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders

Who this might be right for
MucopolysaccharidosisHurler SyndromeHunter Syndrome+10 more
Masonic Cancer Center, University of Minnesota 46
Testing effectiveness (Phase 2)UnknownNCT00698191
What this trial is testing

Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)

Who this might be right for
Refractory Systemic Lupus Erythematosus
Nanjing Medical University 20
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Not applicableUnknownNCT01212796
What this trial is testing

Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH

Who this might be right for
Allogeneic Stem Cell Transplantation
Grupo Espanol de trasplantes hematopoyeticos y terapia celular 350
Testing effectiveness (Phase 2)Study completedNCT00060424
What this trial is testing

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

Who this might be right for
B-Cell Prolymphocytic LeukemiaChronic Lymphocytic LeukemiaProlymphocytic Leukemia+4 more
Fred Hutchinson Cancer Center 21
Next Page